These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
206 related articles for article (PubMed ID: 25772690)
1. High motility group box 1 (HMGB1) protein and its receptor for advanced glycation end products (RAGE) expression in chronic rhinosinusitis without nasal polyps. Dzaman K; Zagor M; Molinska-Glura M; Krzeski A Folia Histochem Cytobiol; 2015; 53(1):70-8. PubMed ID: 25772690 [TBL] [Abstract][Full Text] [Related]
2. Expression of the receptor for advanced glycation end products, a target for high mobility group box 1 protein, and its role in chronic recalcitrant rhinosinusitis with nasal polyps. Dzaman K; Szczepanski MJ; Molinska-Glura M; Krzeski A; Zagor M Arch Immunol Ther Exp (Warsz); 2015 Jun; 63(3):223-30. PubMed ID: 25503556 [TBL] [Abstract][Full Text] [Related]
3. Increased expression of high-mobility group protein B1 in chronic rhinosinusitis. Hong SM; Cho JS; Um JY; Shin JM; Park IH; Lee SH; Lee SH; Lee HM Am J Rhinol Allergy; 2013; 27(4):278-82. PubMed ID: 23883808 [TBL] [Abstract][Full Text] [Related]
4. Correlation Between HMGB1 and TLR4 Expression in Sinonasal Mucosa in Patients With Chronic Rhinosinusitis. Taziki MH; Azarhoush R; Taziki MM; Naghavi-Alhosseini M; Javid N; Davoodi H Ear Nose Throat J; 2019 Dec; 98(10):599-605. PubMed ID: 31238737 [TBL] [Abstract][Full Text] [Related]
5. Increase of high mobility group box chromosomal protein 1 in eosinophilic chronic rhinosinusitis with nasal polyps. Chen D; Mao M; Bellussi LM; Passali D; Chen L Int Forum Allergy Rhinol; 2014 Jun; 4(6):453-62. PubMed ID: 24504744 [TBL] [Abstract][Full Text] [Related]
6. Level of secreted HMGB1 correlates with severity of inflammation in chronic rhinosinusitis. Min HJ; Kim SJ; Kim TH; Chung HJ; Yoon JH; Kim CH Laryngoscope; 2015 Jul; 125(7):E225-30. PubMed ID: 25639490 [TBL] [Abstract][Full Text] [Related]
7. HMGB1/RAGE induces IL-17 expression to exaggerate inflammation in peripheral blood cells of hepatitis B patients. Jhun J; Lee S; Kim H; Her YM; Byun JK; Kim EK; Lee SK; Cho ML; Choi JY J Transl Med; 2015 Sep; 13():310. PubMed ID: 26391982 [TBL] [Abstract][Full Text] [Related]
8. HMGB1 and RAGE in skeletal muscle inflammation: Implications for protein accumulation in inclusion body myositis. Muth IE; Zschüntzsch J; Kleinschnitz K; Wrede A; Gerhardt E; Balcarek P; Schreiber-Katz O; Zierz S; Dalakas MC; Voll RE; Schmidt J Exp Neurol; 2015 Sep; 271():189-97. PubMed ID: 26048613 [TBL] [Abstract][Full Text] [Related]
9. High-mobility group box 1 impairs airway epithelial barrier function through the activation of the RAGE/ERK pathway. Huang W; Zhao H; Dong H; Wu Y; Yao L; Zou F; Cai S Int J Mol Med; 2016 May; 37(5):1189-98. PubMed ID: 27035254 [TBL] [Abstract][Full Text] [Related]
10. Multi-walled carbon nanotube induces nitrative DNA damage in human lung epithelial cells via HMGB1-RAGE interaction and Toll-like receptor 9 activation. Hiraku Y; Guo F; Ma N; Yamada T; Wang S; Kawanishi S; Murata M Part Fibre Toxicol; 2016 Mar; 13():16. PubMed ID: 27026438 [TBL] [Abstract][Full Text] [Related]
11. Up-regulation of the mucosal epidermal growth factor receptor gene in chronic rhinosinusitis and nasal polyposis. Ding GQ; Zheng CQ; Bagga SS Arch Otolaryngol Head Neck Surg; 2007 Nov; 133(11):1097-103. PubMed ID: 18025312 [TBL] [Abstract][Full Text] [Related]
12. HMGB1 binds to activated platelets via the receptor for advanced glycation end products and is present in platelet rich human coronary artery thrombi. Ahrens I; Chen YC; Topcic D; Bode M; Haenel D; Hagemeyer CE; Seeba H; Duerschmied D; Bassler N; Jandeleit-Dahm KA; Sweet MJ; Agrotis A; Bobik A; Peter K Thromb Haemost; 2015 Nov; 114(5):994-1003. PubMed ID: 26202300 [TBL] [Abstract][Full Text] [Related]
13. Clinical use of high mobility group box 1 and the receptor for advanced glycation end products in the prognosis and risk stratification of heart failure: a literature review. Marsh AM; Nguyen AH; Parker TM; Agrawal DK Can J Physiol Pharmacol; 2017 Mar; 95(3):253-259. PubMed ID: 28092162 [TBL] [Abstract][Full Text] [Related]
14. [Correlation between the expression of high mobility group box 1 and receptor for advanced glycation end products and the onset of pre-eclampsia]. Gao L; Liu WH; Luan NN; Feng C; Shang T Zhonghua Fu Chan Ke Za Zhi; 2008 Oct; 43(10):746-50. PubMed ID: 19087540 [TBL] [Abstract][Full Text] [Related]
15. Mucosal expression of nerve growth factor and brain-derived neurotrophic factor in chronic rhinosinusitis. Coffey CS; Mulligan RM; Schlosser RJ Am J Rhinol Allergy; 2009; 23(6):571-4. PubMed ID: 19958603 [TBL] [Abstract][Full Text] [Related]
16. HMGB1-TLR4 signaling contributes to the secretion of interleukin 6 and interleukin 8 by nasal epithelial cells. Shimizu S; Kouzaki H; Kato T; Tojima I; Shimizu T Am J Rhinol Allergy; 2016 May; 30(3):167-72. PubMed ID: 27216346 [TBL] [Abstract][Full Text] [Related]
17. The role of superantigens in chronic rhinosinusitis with nasal polyps. Wang M; Shi P; Chen B; Zhang H; Jian J; Chen X; Wang Z; Zhang D ORL J Otorhinolaryngol Relat Spec; 2008; 70(2):97-103. PubMed ID: 18408407 [TBL] [Abstract][Full Text] [Related]
18. Quercetin protects necrotic insult and promotes apoptosis by attenuating the expression of RAGE and its ligand HMGB1 in human breast adenocarcinoma cells. Dhumale SS; Waghela BN; Pathak C IUBMB Life; 2015 May; 67(5):361-73. PubMed ID: 25983116 [TBL] [Abstract][Full Text] [Related]
19. Molecular and cellular staging for the severity of chronic rhinosinusitis. Kountakis SE; Arango P; Bradley D; Wade ZK; Borish L Laryngoscope; 2004 Nov; 114(11):1895-905. PubMed ID: 15510011 [TBL] [Abstract][Full Text] [Related]
20. Regional expression of epithelial MDR1/P-glycoprotein in chronic rhinosinusitis with and without nasal polyposis. Bleier BS Int Forum Allergy Rhinol; 2012; 2(2):122-5. PubMed ID: 22223515 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]